Paxlovid and Molnupiravir Reduce Mortality and Hospitalisation in High-Risk Omicron-Infected Patients Dr Riya Dave23 Sept 2023 11:30 AM ISTRitonavir-boosted Nirmatrelvir and Molnupiravir, two oral antiviral drugs currently used to treat nonhospitalized COVID-19 patients at high risk of...
Common medicine can stop the transmission of HIV infection from mother to child Dr. Kamal Kant Kohli19 Jan 2023 10:00 AM ISTAntiviral drugs almost completely reduce the risk of mothers passing on HIV infection to their children, even in a low-income country with a high HIV...
Combatting the second COVID 19 wave in India: Defining the role of Favipiravir dr. Abhimanyu Uppal12 May 2021 12:45 PM ISTAs India battles the second COVID-19 wave across all states, the healthcare system is overburdened with daily cases skyrocketing to more than 1.5 lac...
Combating COVID-19: GSK, Vir Biotechnology enter race to find antiviral drugs Medical Dialogues Bureau1 Sept 2020 9:45 AM ISTNew Delhi: GlaxoSmithKline and partner Vir Biotechnology have started testing their experimental antibody on early-stage COVID-19 patients, entering...
HIV Patient "First In Remission" Without Transplant, Say Researchers Hina Zahid9 July 2020 8:15 AM ISTParis: A HIV-positive man in remission may be the first patient effectively cured of the illness without needing a bone marrow transplant, researchers...
Glenmark to Commence Another New Phase 3 Clinical Trial India testing on Combination of Favipiravir, Umifenovir Moderate COVID-19 hospitalised patients Ruchika Sharma26 May 2020 1:48 PM ISTThe new combination clinical trial will be called FAITH - (Favipiravir plus Umifenovir (efficacy & safety) Trial in an Indian Hospital setting)
